Latest Capital Raises News

Microba Life Sciences announces a $12.5 million equity raise, including a strategic $8.3 million investment from Sonic Healthcare, aiming to fuel growth in the UK and achieve regional break-even by FY26.

Microba Life Sciences has raised $14.5 million to accelerate clinical adoption of its microbiome testing products, while narrowing its FY25 revenue guidance and signing a strategic UK laboratory agreement.

Orbminco is launching an extended drilling campaign at its Majestic North Gold Project near Kalgoorlie, aiming to confirm and grow its 39,700-ounce resource. The company is also raising an additional A$0.205 million to fund this ambitious exploration push.

Sunrise Energy Metals has secured $6 million through a placement and is seeing strong support for its Share Purchase Plan, aiming to fast-track the Syerston Scandium Project feasibility study by Q3 2025.

MA Income Credit Trust (ASX, MA1) has launched a placement to raise nearly A$50 million, aiming to bolster its exposure to private credit through new unit issuance at a slight discount. The capital will fund investments across direct lending, asset-backed lending, and corporate lending segments.

MA Income Credit Trust (ASX – MA1) has launched a fully underwritten wholesale placement to raise nearly $50 million, aiming to bolster its credit investment portfolio. The placement will issue over 24.8 million new units at $2.00 each without requiring securityholder approval.

MA Income Credit Trust (ASX, MA1) has launched a fully underwritten wholesale placement to raise nearly $50 million, issuing new units at $2.00 each. The capital will support its core credit investment strategy without requiring securityholder approval.

Boab Metals has successfully raised $6 million through a share placement and an ATM set-off, positioning the company to advance its Sorby Hills Project in Western Australia.

Alligator Energy has raised A$17.25 million through a strongly supported placement to institutional investors, positioning the company to advance key development stages at its Samphire Uranium Project. The funds will underpin exploration, feasibility studies, and the upcoming Field Recovery Trial.

Invion Limited has announced a fully underwritten entitlement offer of Loyalty Options to raise capital for advancing its cancer clinical trials. The offer, led by Blue Ocean Equities and supported by CEO Prof Thian Chew, invites eligible shareholders to participate in a non-renounceable rights issue.

Prominence Energy has agreed to acquire a vast natural hydrogen and helium exploration portfolio on the Gawler Craton, backed by a $1.75 million capital raise and strategic board appointments.

Universal Biosensors has requested a voluntary suspension of its shares on the ASX, pending details of a proposed capital raising. The suspension is expected to last until the end of June or until the announcement is made.